Product Information
BUDESONIDE 1 MG/2 ML INH SUSP is a generic product labeled by Sandoz Inc., priced at $4.0893 per ML under NDC 00781751787. Its NADAC has been published 496 times since Nov 18, 2015.
FDA first approved this application on Sep 27, 2013.
Strength
1 mg/2mL
Manufacturer
Sandoz Inc.NDC
00781751787
Classification
Generic
Dosage Form
SUSPENSION
Route
RESPIRATORY (INHALATION)
Effective Date
4/23/2025
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA201966FDA Approved
9/27/2013
On Market Since
7/24/2015
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE 1 MG/2 ML INH SUSP has been published 496 times since Nov 18, 2015, and over the history we have for it it has declined 55.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.0893 per ML |
|---|---|
| All-time high | $9.5184 (Jan 13, 2016) |
| All-time low | $2.9762 (May 22, 2024) |
| Median price | $4.3390 |
| Average price | $5.1728 |
| Largest weekly change | -26.6% (Apr 17, 2024) |
| Weeks tracked | 496 |
| Tracking since | Nov 18, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+1.3%
5Y
+11.5%
All
-55.8%
Last surveyed May 14, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sandoz Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Budesonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of BUDESONIDE 1 MG/2 ML INH SUSP?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE 1 MG/2 ML INH SUSP, manufactured by Sandoz Inc., is $4.0893 per ML (NDC 00781751787), effective May 14, 2025.
How has the price of BUDESONIDE 1 MG/2 ML INH SUSP changed over time?
Over the history we have for it, the NADAC for BUDESONIDE 1 MG/2 ML INH SUSP has declined 55.8%. It has been tracked across 496 weekly CMS publications since Nov 18, 2015.
What are the highest and lowest recorded NADAC prices for BUDESONIDE 1 MG/2 ML INH SUSP?
Since Nov 18, 2015, the NADAC for BUDESONIDE 1 MG/2 ML INH SUSP has ranged from a low of $2.9762 (May 22, 2024) to a high of $9.5184 (Jan 13, 2016), with a median of $4.3390 per ML.
Are there cheaper alternatives to BUDESONIDE 1 MG/2 ML INH SUSP?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BUDESONIDE 1 MG/2 ML INH SUSP, is $3.4274 per ML — about 16% below BUDESONIDE 1 MG/2 ML INH SUSP.
Who manufactures BUDESONIDE 1 MG/2 ML INH SUSP?
BUDESONIDE 1 MG/2 ML INH SUSP (NDC 00781751787) is labeled by Sandoz Inc., and CMS classifies it as a generic product.